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Prolongation of length of stay and Clostridium
difficile infection: a review of the methods used to
examine length of stay due to healthcare
associated infections
Brett G Mitchell1* and Anne Gardner1,2
Abstract
Background: It is believed that Clostridium difficile infection (CDI) contributes to a prolongation of length of stay
(LOS). Recent literature suggests that models previously used to determine LOS due to infection have overestimated
LOS, compared to newer statistical models. The purpose of this review is to understand the impact that CDI has on
LOS and in doing so, describe the methodological approaches used.
Aim: First, to investigate and describe the reported prolongation of LOS in hospitalised patients with CDI. Second,
to describe the methodologies used for determining excess LOS.
Methods: An integrative review method was used. Papers were reviewed and analysed individually and themes
were combined using integrative methods.
Results: Findings from all studies suggested that CDI contributes to a longer LOS in hospital. In studies that
compared persons with and without CDI, the difference in the LOS between the two groups ranged from 2.8 days
to 16.1 days. Potential limitations with data analysis were identified, given that no study fully addressed the issue of
a time-dependent bias when examining the LOS. Recent literature suggests that a multi-state model should be
used to manage the issue of time-dependent bias.
Conclusion: Studies examining LOS attributed to CDI varied considerably in design and data collected. Future
studies examining LOS related to CDI and other healthcare associated infections should consider capturing the
timing of infection in order to be able to employ a multi-state model for data analysis.
Keywords: Clostridium difficile infection, Clostridium difficile associated diarrhoea, Cost, Healthcare associated
infection, Length of stay, Time dependent bias
Background
Clostridium difficile infection (CDI) is the leading cause
of infectious diarrhoea in hospitalised patients [1].
According to the Centers for Disease Control and
Prevention (CDC), the annual incidence of CDI in the
USA exceeds 250 000 hospitalised cases, with a mortality
of 1–2.5% [2]. The disease’s symptoms can range from
colonisation to life-threatening colitis. The incidence of
morbidity related to CDI is increasing due to an
epidemic of a hypervirulent strain of C.difficile
(BI/NAP1) that has been reported in the USA and other
countries. In addition to significant morbidity and
mortality, CDI increases healthcare costs due to patients’
extended hospitalisations and re-hospitalisations [3]. A
recent systematic review investigating the economic
costs to healthcare associated with CDI concluded that
despite a lack of common methods employed by the
studies, it is clear that the economic consequences of
CDI are considerable [4].
One important step towards understanding the burden
that CDI has on the health service is to examine the
economic cost of CDI in hospitalised patients. One of the
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major costs associated with any healthcare associated
infection (HAI) is excess hospitalisation, or prolongation
of length of stay (LOS). A challenge for researchers is to
design a study that accurately accounts for prolonged
lengths of stay. Recent literature suggests that models that
have been previously used to determine the additional
LOS in hospital due to infection overestimated the
additional LOS, compared to newer statistical models
[5-10]. It is therefore vital that studies are designed in such
a way as to evaluate and analyse this effectively. Determin-
ing the additional LOS due to an HAI, including CDI, is
challenging due to the need to manage time-dependent
bias—that is, the longer a person stays in hospital, the
greater the risk of acquiring an infection. Time dependent
bias is a term used to describe problem occurring
when variables in the model change value after the start of
patient observation. Such variables are called “time
dependent,” because their value can change over time [11].
One study demonstrating this bias examined readmission
hospital and whether persons with a discharge summary
were followed up by a physician after discharge. When the
time dependent variable was analysed as a fixed variable,
there were significantly lower readmissions in patients
who saw physicians with the summary. This was shown
to be a biased association as patients with early hospital
readmission did not have a chance to see a physician and
these patients were placed in a ‘non discharge summary’
group [12]. There are numerous other publications which
also demonstrate this issue [7-9,13,14]
Therefore, managing issues such as time-dependent bias
and sampling bias are important. The purpose of this
review is to understand the impact that CDI has on LOS
in hospitalised patients and, in doing so, to describe the
methodological approaches used.
Methods
Design
An integrative review design was used in the same manner
as described by Whittemore and Knafl [15]. To allow for a
synthesis of results, an integrative design was selected
based on the summation of different methodological
approaches used in the empirical and theoretical literature.
As a result, the design provides a more comprehensive
understanding of particular issues [15].
Search strategy
The literature was accessed through searches on electronic
databases Medline and Pubmed and was limited to the 1st
January 2000 to 30 April 2011. Other limits included only
searching literature that was published in English and stud-
ies involving humans. Key terms used were “Clostridium
difficile and economic”, “Clostridium difficile and length of
stay”, “Clostridium difficile and cost” and “Clostridium
difficile and burden”. These searches were combined, with
duplicate studies being removed. Following this step, a
review of these articles was conducted. Only case-
controlled, cohort or review studies were included. Further-
more, articles were only included if they examined the LOS
of hospitalised patients with CDI. Finally, letters to the
editor and interventional studies, for example the effect of
immunoglobulin treatment on LOS, were excluded.
Search outcome
The initial search yielded 330 articles. After the removal of
studies that were not case-controlled, cohort or review
studies, 26 studies remained. A further ten articles were
excluded because they were either letters to the editor or
were interventional studies. Figure 1 summarises the
search strategy and outcomes.
Results
The majority of the 16 studies identified through the
search strategy were retrospective in design. Two reviews
and two prospective studies were identified. Table 1 sum-
marises the characteristics and results from the 16 studies
identified for this review.
The search strategy used to identify articles for this re-
view did not identify the same articles in the latest review
published by Ghantoji, Sail et al. [4]. Two articles included
in the review by Ghantoji, Sail et al. [4] were not include in
our review. Conversely, our study identified and included
eight studies not used by Ghantoji, Sail et al. [4]. The pri-
mary reason for both these discrepancies is that our review
examined the prolongation of LOS, whereas the focus by
Ghantoji, Sail et al. [4] was economic cost . Similarly our
review did not include two articles identified by the review
conducted by Dubberke & Wertheimer (2009), but did
identify a further 11 articles not used by Dubberke &
Wertheimer (2009). The reasons for this are the same as
those just previously described in addition to the inclusion
of recent publications. Nine articles were common to both
reviews. The review by Ghantoji, Sail et al. [4] identified
four articles not identified by Dubberke & Wertheimer
(2009). Conversely, Dubberke & Wertheimer (2009) iden-
tified five articles not used by Ghantoji, Sail et al. [4].
The manner in which participants were identified for
the studies differed, with several studies using Inter-
national Classification of Disease (ICD) codes to identify
cases [16-21]. The use of ICD codes to identify participants
does have the potential to reduce sensitivity and specificity
when identifying cases of CDI as coding data is likely to
underestimate cases. In addition, coding practices can vary
between hospitals, and therefore multi-centred studies
have a greater potential for variation in sample selection.
Furthermore, the timing of an episode of CDI cannot be
determined by such an approach.
Excluding the reviews, only three of the remaining
fourteen studies were undertaken in countries other than
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the United States. The systematic review examining the
economic costs of CDI undertaken by Ghantoji, Sail et al.
[4] identified only four of thirteen articles from the
United States. In the review undertaken by Dubberke and
Wertheimer [22], one Australian study undertaken was
identified as having been published as a letter to the
editor [23].
The data collected in the various studies differed
considerably. The majority of studies collected basic
demographic data, such as age and gender. Some studies
collected data about co morbidities and used a severity
index such as the Charlson co morbidity index [18,24,25].
Data collected about variables such as antibiotic exposure
or other drug therapies were limited [25-27].
Findings from all studies suggested that CDI contributes
to a longer LOS in hospital. It was not possible to pool data
because studies varied considerably in design, sampling and
data analysis techniques. In studies that used a comparison
between persons with CDI and those without, the difference
in the LOS between the two groups ranged from 2.8 days to
16.1 days [24,28]. These data suggest that CDI does play a
role in increasing the LOS in hospital.
In a retrospective cohort of over 18 000 non-surgical
patients hospitalised for more than 48 h, Dubberke et al.
[24] took a nested subset using a matched-pairs analysis
and found that the increase in LOS that could be attribu-
ted to CDI was 2.8 days. Controls were matched to cases
by a propensity score developed for data analysis. Using
logistic regression, patient-specific probabilities of develop-
ing CDI were developed. The median LOS was determined
for cases and controls, with the various median pair-wise
lengths of stay being compared by using the Wilcoxon
signed-ranked test. Attributable LOS was determined by
calculating the median pair-wise difference between CDI
cases and the controls [24]. As this study did not include
surgical patients, it is possible that patients with severe
CDI, those requiring colectomies, were excluded, leading
to a potential bias. The use of a propensity score to match
controls was used in an attempt to reduce any potential
bias between controls and cases when determining CDI-
attributable LOS.
A study undertaken by Lumpkins et al. [28] suggested a
considerably longer LOS then that reported by Dubberke
et al. [24]. In a prospective cohort study comprising of
critically ill patients admitted to an intensive care unit, those
with and without CDI were compared. A logistic regression
model was used for data analysis. The mean hospital LOS
was 15.9 days greater in patients who developed CDI com-
pared to those who did not (34.9 days versus 19.0 days,
p=0.003). When cases were compared regarding antibiotic
exposure, those with minimal exposure were found to have
a shorter LOS in hospital, but data regarding all antibiotic
exposure prior to admission, such as outpatients, were not
obtained in this study [28]. Such a finding would suggest
that collecting data on antibiotic exposure is needed in
future studies that employ a similar methodology.
The methods of data analysis varied, as shown in Table 1.
In the majority of studies, a regression model was devel-
oped to determine the impact that CDI had on LOS
[16,18,20,21,24,26-30]. The studies did not collect data
concerning the time of onset of CDI; therefore, it is not
possible to exclude the possibility of reverse causality, in
Figure 1 Summary of search strategy. 1Articles were excluded if they were not case controlled, cohort or review studies or if they did not
examine length of stay in hospitalised patients. 2Letters to the editor and interventional studies were excluded.
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which longer lengths of hospitalisation may have increased
the risk of CDI. The issues associated with controlling for
a potential time-dependent bias caused by the LOS in
hospital raises some significant concerns, which will now
be discussed.
Discussion
As demonstrated in a published systematic review examin-
ing the economic costs of CDI, the focus of many studies
was to view costs through the eyes of an accountant [4].
An accountant’s model for determining the cost of HAIs is
to count fixed and variables costs. Variable costs may
include items such as dressings, personal protective
equipment and laboratory test materials. Fixed costs
include salary, electricity and heating. As fixed costs are
often jointly shared—for example, one doctor does not
treat one patient—the accountant’s model determines a
measure of usage for these fixed costs (cost per unit) and
allocates this to patients or to the health provider accord-
ingly. Comparisons between the average cost per infected
patient and average cost per non-infected patient are often
used to attribute the cost of HAIs. However, this may be
misleading [31]. According to Graves, using such a model
is not suitable for economic appraisal or for informing
decisions about HAIs. An implication of the economic
model is that by reducing or eradicating a specific infec-
tion, a fixed figure could be saved. An accountant’s model
ignores the cost of increased investments towards reducing
infections and fails to consider which costs actually change
with infections, as many fixed costs remain [31].
Table 1 Summary of included articles
Author Study type Country Statistical analysis Results
Ananthakrishnan, McGinley,
& Binion 2008
Retrospective case control US Multivariate regression Three times the length of stay
(CDI + IBD)
vs. controls (IBD) IBD= irritable
bowel disease
Bajaj et al. 2010 Retrospective case control US Multivariate regression 12.7-day case vs. 6.7-day
control
Dubberke, Butler et al. 2008 Retrospective cohort US Multivariate regression,
matched-pairs analysis
9.6-day cases vs. 5.8-day
controls
Dubberke & Wertheimer 2009 Review Not applicable Not applicable Not applicable
Ghantoji et al. 2010 Review Not applicable Not applicable Not applicable
Kenneally et al. 2007 Retrospective cohort US Multiple logistic regression 27.3 (CDI) vs. 22.8 (non CDI)
Lawrence et al. 2007 Retrospective cohort US Multiple logistic regression CDI stay twice as much non-
CDI in ICU
Lumpkins et al. 2008 Prospective cohort US Multiple logistic regression 34.9 day LOS with CDI vs. 19
LOS without CDI
Miller et al. 2002 Retrospective cohort Canada Not discussed 9% of 269 patients with CDI
deemed to have extension of
LOS due to CDI
Nguyen, Kaplan, Harris,
& Brant 2008
Retrospective cohort US Multiple linear regression 65% increase in LOS in
patients with CDI & Crohn’s
disease 46% increase in LOS in
patients with CDI & ulcerative
colitis
O’Brien, Lahue, Caro,
& Davidson 2007
Retrospective cohort US Descriptive 6.4-day LOS in patients with
primary CDI diagnosis
Pepin, Valiquette,
& Cossette 2005
Retrospective case control Canada Not discussed 10.7-day additional LOS in
patient with CDI
Song et al. 2008 Retrospective match cohort US Logistic regression
Wilcoxon Linear regression
1-day LOS increase (with CDI)
4-day LOS increase (CDI)
when compared to matched
diagnosis related group DRG
Vonberg et al. 2008 Prospective match cohort Germany Wilcoxon Kolmogorov-Smirnov
test
27-day LOS cases vs. 20-day
LOS controls
Zerey et al. 2007 Retrospective cohort US Multiple logistic regression 16-day-longer LOS (with CDI)
Zilberberg et al. 2009 Retrospective cohort US Propensity score
Multivariate analysis
6.1-day longer LOS (with CDI)
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An economist model uses a cost-analysis approach to
determine if there are any savings. For example, the
consumables may be reduced by decreasing the instances of
HAIs. The capacity gained by a reduction in HAIs is valu-
able and should thus be redeployed for other use. The
redeployment of resources could be used for tasks such as
elective surgery and, in turn, could cause other variable
costs to increase [31].
An economist’s approach in evaluating the cost of HAIs
is supported by the argument that the majority of the costs
associated with hospital care are fixed [32,33]. Therefore, in
describing how costs change in relation to HAIs, it is
important to demonstrate the number of bed days caused
by HAIs [31]—and therefore the number of beds that are
made available by preventing these infections—before
deciding who will utilise these extra beds. Accurately
determining the prolongation of LOS due to CDI will assist
in developing an economic model for its prevention and
control.
All of the studies identified in this literature review
suggested that CDI contributes to a longer LOS in hos-
pital. However, the method used to determine LOS should
account for the fact that an HAI, such as CDI, can occur
at any point during hospitalisation and that LOS is affected
by other variables, such as co morbidity and primary diag-
nosis [5]. Matched cohort studies suffer from two types of
bias. First, insufficient matching will not control all the
bias. Second, strict matching criteria will result in censor-
ing. The variable nature of when the infection might have
started also poses an issue in matched studies: infections
can occur at any time. However, data analysis in matched
studies often compared infected and uninfected patients
by their total hospital stay. If the timing of infections is not
taken into account, then costs associated with pre- and
post-infection are included and can dramatically amplify
the time-dependent bias [5]. Statistical models can be used
to address this issue at the data-analysis stage rather than
at the design stage. A model can be built to describe the
relationship between LOS and the predictors of that out-
come [5,34]. Previously, models that ignored the time of
infection often used a linear model that assumed a gamma
distribution, where waiting times between events are rele-
vant, in this case LOS and an independent variable of
infected (“yes” or “no”) [14]. One recent study examining
CDI did attempt to use the principles of managing time-
dependent bias in their study [35].
Methods have recently been developed to address these
issues when estimating LOS associated with healthcare-
associated infections. These methods include a multi-state
model in which the infection is the intermediate event
between admission and discharge and in which patients are
given one of three states: non-infected, infected and dis-
charged [6,14,36]. Therefore, for future research examining
the prolongation of LOS for people with an HAI including
CDI, collecting data at the commencement and completion
of infection will enable the use of a multi-state model in
data analysis.
Conclusion
Studies examining lengths of stay attributed to CDI
varied considerably in their design and the data they
collected. Several studies used administrative codes, such
as ICD codes, to identify cases of CDI. The use of
administrative data for this purpose did lead to some
limitations, including the potential for ascertainment bias
and a lack of sensitivity and specificity. A limited number
of studies captured data regarding co morbidities. Co
morbidities would clearly influence the LOS in hospital,
and therefore this information should be collected when
possible. Researchers, should consider whether data
concerning antibiotic exposure needs to be included in
future studies.
Despite these differences, there was a clear indication that
CDI played some role in prolonging hospitalised patients’
lengths of stay. As LOS in a hospital is a major contributor
to healthcare cost, it is a logical assumption that CDI con-
tributes an economic cost to the health system, a view
shared by Ghantoji, Sail et al. [4]. Only a very limited num-
ber of studies identified in this literature review or in
the two published reviews by Ghantoji, Sail et al. [4] and
Dubberke and Wertheimer [22] did so outside of the United
States or Canada. The provision of health services and the
epidemiology of CDI varies between countries, and thus it
is vital that future studies are undertaken in a variety of
countries. In particular, studies outside of the United States
and Canada are needed.
Potential issues in data analysis were identified, given that
no study fully addressed the issue of a time-dependent bias
when examining the LOS caused by CDI. Recent literature
suggests that a multi-state model should be used to manage
the issue of time-dependent bias. In order for a multi-state
model to be used, the timing of CDI infection must be cap-
tured. However, no study identified in the literature search,
including the two published reviews examining the eco-
nomic cost of CDI, used or identified a multi-state model
design. In fact, no study identified the onset and cessation
of CDI infection and used this data to inform data analysis.
Future studies examining LOS and CDI should consider
capturing the timing of CDI infection in order to be able to
employ a multi-state model for data analysis. Such an
approach can also be extended in order to study HAIs other
than CDI.
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